Invention Grant
- Patent Title: Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
-
Application No.: US14506181Application Date: 2014-10-03
-
Publication No.: US09987227B2Publication Date: 2018-06-05
- Inventor: David C. Cipolla , Igor Gonda
- Applicant: ARADIGM CORPORATION
- Applicant Address: US CA Hayward
- Assignee: ARADIGM CORPORATION
- Current Assignee: ARADIGM CORPORATION
- Current Assignee Address: US CA Hayward
- Agency: Bozicevic Field & Francis LLP
- Agent Karl Bozicevic
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/496 ; A61K47/10 ; A61K47/26 ; A61K9/00

Abstract:
Methods for formulating and compositions of immediate and sustained release liposomal products which comprise a surfactant that interacts with liposomes to effect drug release therefrom, and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
Public/Granted literature
Information query